stockrowNeurocrine Biosciences, Inc.
NBIX Healthcare Drug Manufacturers Specialty & Generic
Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024.
- Revenue
- +41.2%
- EPS
- −3.67%
- Free cash flow
- +79.0%
Quarter to September 2026, against a year earlier
Follow NBIX
Alert me
Neurocrine Biosciences, Inc. (NBIX) Total debt
Neurocrine Biosciences, Inc.'s total debt at the end of fiscal 2022 was $281.0M, down 16.1% from $335.1M in fiscal 2021. At the end of the quarter to 30 September 2023 it was $274.0M. Over the past ten years it has ranged from $617.0K (fiscal 2016) to $388.5M (fiscal 2018); the current reading is higher than 50% of that period. Neurocrine Biosciences, Inc. ranks 27th of 84 Drug Manufacturers Specialty & Generic companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2022 | $281.0M | (16.14%) |
| FY2021 | $335.1M | 5.41% |
| FY2020 | $317.9M | 265.40% |
| FY2019 | $87.0M | (77.61%) |
| FY2018 | $388.5M | 5.11% |
| FY2017 | $369.6M | 59,805.67% |
| FY2016 | $617.0K | (66.17%) |
| FY2015 | $1.8M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2023 | $274.0M | (0.72%) |
| Jun 2023 | $276.0M | 62.83% |
| Mar 2023 | $169.5M | 80.32% |
| Dec 2022 | $94.0M | (3.09%) |
| 31 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| HLN Haleon PLC Sponsored ADR compare | $11.1B |
| ZTS Zoetis Inc. compare | $9.0B |
| ELAN Elanco Animal Health Incorporated compare | $3.9B |
| VTRS Viatris Inc. compare | $1.7B |
| ALKS Alkermes plc compare | $1.5B |
| RDY Dr. Reddy's Laboratories Ltd compare | $753.0M |
| NBIX Neurocrine Biosciences, Inc. | $274.0M |
| UTHR United Therapeutics Corporation compare | $200.0M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $13.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on NBIX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement